Mirum Pharmaceuticals Inc (MIRM) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.36x

Mirum Pharmaceuticals Inc (MIRM) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting $2.21 Million (capex $600.00K plus investments $1.61 Million) from operating cash flow of $6.07 Million. Check Mirum Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.36x
(Capex + Investments) / Operating CF

Total Reinvested

$2.21 Million
Capex + Investments

Operating Cash Flow

$6.07 Million
USD

Capital Expenditures

$600.00K
USD

Mirum Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2025)

Historical reinvestment intensity for Mirum Pharmaceuticals Inc across 2 annual periods. Explore investment intensity of Mirum Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Mirum Pharmaceuticals Inc (2024–2025)

Year-by-year capital reinvestment analysis for Mirum Pharmaceuticals Inc. For live market cap and broader valuation context, see Mirum Pharmaceuticals Inc (MIRM) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.43x $23.95 Million $55.83 Million $954.00K ▼ -95.1%
2024 8.82x $91.12 Million $10.32 Million $993.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow